Psychology & Psychiatry

Research finds biomarkers in older adults with late-life depression

Major depression in older adults is very common, disabling, and increases the risk of many diseases of aging, including Alzheimer's disease and other dementias, cardiovascular issues and even mortality. Therefore, it constitutes ...

Diseases, Conditions, Syndromes

COVID-19 lockdown may have increased suicidal thoughts

The lockdowns during the COVID-19 pandemic had a significant effect on levels of suicidal ideation, a new study finds. The research, published in Open Medicine, was conducted in a Serbian psychiatric clinic shortly after ...

Medications

NSAID improves vascular health in adults with severe depression

Science has long established a link between depression and cardiovascular disease, but the precise nature of the connection is less clear. In a new proof-of-concept study, researchers worked to zero in on the mechanism behind ...

Psychology & Psychiatry

Expert explains differences between adult and teen depression

Clinical depression is a mood disorder than can affect anyone and at any age. The signs and symptoms, however, are not the same for everyone. Marcie Billings, M.D., a Mayo Clinic Children's Center pediatrician, says there ...

Psychology & Psychiatry

Using ketamine to find an undiscovered pathway in depression

For the 280 million people suffering from depression globally, relief cannot come fast enough. Monoaminergic antidepressants, including selective serotonin reuptake inhibitors (SSRIs) take weeks to months to take effect and ...

Psychology & Psychiatry

New research maps how the brain changes during depression treatment

For the first time, researchers have shown what happens to the brain when a person receives a depression treatment known as repetitive transcranial magnetic stimulation (rTMS). The results were published today in the American ...

Psychology & Psychiatry

Many young adults with depression not receiving treatment

Many young adults with a major depressive episode (MDE) do not receive any treatment, with cost being the most prominent barrier, according to a research letter published online May 10 in JAMA Network Open.

page 9 from 30